• Explore /
  • Poster
  • / Final results of a phase I trial of HERV-E TCR transduced T cells for the treatment of HLA-A*11 patients with metastatic clear cell renal cell carcinoma (mccRCC).

Final results of a phase I trial of HERV-E TCR transduced T cells for the treatment of HLA-A*11 patients with metastatic clear cell renal cell carcinoma (mccRCC).

Abstract Poster

Authors

null

Rosa Nadal

National Heart, Lung, and Blood Institute, Bethesda, MD

Rosa Nadal , Stefan Barisic , Gina M. Scurti , Elena Cherkasova , Long Chen , Kristen Wood , Steven L. Highfill , Brian Wells , Georg Aue , Reem Shalabi , Thomas E. Hughes , Xin Tian , Yifei Xu , Ashkan A. Malayeri , Robert N. Reger , Michael I. Nishimura , Richard W. Childs

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 435)

DOI

10.1200/JCO.2024.42.4_suppl.435

Abstract #

435

Poster Bd #

H17

Abstract Disclosures

Similar Posters

First Author: Rosa Nadal

First Author: Hans J. Hammers

First Author: Rodabe Navroze Amaria

First Author: Carlos A. Gomez-Roca